| #1113 |
Gemma Zünd |
Basf Se |
1 |
| #1113 |
Joerg Brozio |
Novartis Ag |
1 |
| #1113 |
Sarah Hopper |
Syngenta Participations Ag |
1 |
| #1113 |
Stephanie Portmann |
Basf Se |
1 |
| #1113 |
Petr Znamenskiy |
Cold Spring Harbor Laboratory |
1 |
| #1113 |
Svenja Gschwind |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Michal Jurí{hacek over (c)}ek |
Northwestern University |
1 |
| #1113 |
Johannes Singler |
— |
1 |
| #1113 |
Karolina Kruszynska |
Forschungszentrum Borstel |
1 |
| #1113 |
Harriet Struthers |
Merck |
1 |
| #1113 |
Rahel Heule |
Universitatsspital Basel |
1 |
| #1113 |
Martin Renatus |
Novartis Ag |
1 |
| #1113 |
Assaf Levi |
Bioversys Ag |
1 |
| #1113 |
Mareike Beck |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Phillippe Lindenmann |
Depuy Synthes Products |
1 |
| #1113 |
Pierre Elemans |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Adriaan Willem Meesen |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Cindy Gerhardt |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Rob Markus |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Christiane Maier |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Aurelie Brelin |
Novozymes A/S |
1 |
| #1113 |
Miloud Achour |
Novartis Ag |
1 |
| #1113 |
Christian Stehli |
Aktiebolaget Skf |
1 |
| #1113 |
Manuel Koechlin |
Rolic Ag |
1 |
| #1113 |
Florence Tixeront |
Hoffmann-La Roche |
1 |
| #1113 |
David Egli |
Straumann Holding Ag |
1 |
| #1113 |
Philipp Knechtle |
Evolva |
1 |
| #1113 |
Alex Bruderer |
Atotech Deutschland |
1 |
| #1113 |
Julie Lachal |
Novartis Ag |
1 |
| #1113 |
Diana Graus Porta |
Novartis Ag |
1 |
| #1113 |
Iris Staudecker |
— |
1 |
| #1113 |
Perle Nganga |
Novartis Ag |
1 |
| #1113 |
Rudolf Schenker |
Novartis Ag |
1 |
| #1113 |
Tobias Remus |
Polyphor Ag |
1 |
| #1113 |
Sebastian Kopec |
Novartis Ag |
1 |
| #1113 |
Melinda Eniko Grubesa |
Novartis Ag |
1 |
| #1113 |
Beat Henrich |
Paul Scherrer Institut |
1 |
| #1113 |
Lilla Di Scala |
Roche Glycart Ag |
1 |
| #1113 |
Arndt Meyer |
Novartis Ag |
1 |
| #1113 |
Markus Driess |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Thomas Hefti |
Thommen Medical Ag |
1 |
| #1113 |
Cornelia Irl |
Genentech |
1 |
| #1113 |
Kerstin Den Brave |
Dsm Ip Assets B.V. |
1 |
| #1113 |
Sascha Gysin |
Basf Se |
1 |
| #1113 |
Frauke Assmus |
Hoffmann-La Roche |
1 |
| #1113 |
Stephen Wilson Skillman |
Syngenta Participations Ag |
1 |
| #1113 |
Karsten Hipler |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
1 |
| #1113 |
Silvia Heuerding |
Novartis Ag |
1 |
| #1113 |
Matthias Mertmann |
Black & Decker |
1 |
| #1113 |
Andreas Michael Vogel |
Exelixis |
1 |